Press Release: Sanofi and CD&R sign Opella share purchase agreement

Core Points - Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% controlling stake in Opella to CD&R, with Bpifrance expected to hold a minority stake of approximately 2% [1][2] - The transaction is subject to customary regulatory approvals and is expected to close in Q2 2025 at the earliest [2] Company Overview - Sanofi is an innovative global healthcare company focused on improving people's lives through scientific advancements, providing life-changing treatments and vaccines globally, while emphasizing sustainability and social responsibility [3]